These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7558942)

  • 21. [HLA-G and local placental immunity].
    Le Bouteiller P
    Gynecol Obstet Fertil; 2003 Sep; 31(9):782-5. PubMed ID: 14499728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival.
    Menier C; Riteau B; Dausset J; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2000 Nov; 61(11):1118-25. PubMed ID: 11137216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells.
    Mallet V; Pröll J; Solier C; Aguerre-Girr M; DeRossi M; Loke YW; Lenfant F; Le Bouteiller P
    Hum Immunol; 2000 Mar; 61(3):212-24. PubMed ID: 10689111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses.
    Yao YQ; Barlow DH; Sargent IL
    J Immunol; 2005 Dec; 175(12):8379-85. PubMed ID: 16339579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma.
    Yang Y; Chu W; Geraghty DE; Hunt JS
    J Immunol; 1996 Jun; 156(11):4224-31. PubMed ID: 8666791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-G: expression in human keratinocytes in vitro and in human skin in vivo.
    Ulbrecht M; Rehberger B; Strobel I; Messer G; Kind P; Degitz K; Bieber T; Weiss EH
    Eur J Immunol; 1994 Jan; 24(1):176-80. PubMed ID: 8020553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion.
    Haga JA; She JX; Kao KJ
    J Biol Chem; 1991 Feb; 266(6):3695-701. PubMed ID: 1995624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1.
    Moreau P; Paul P; Gourand L; Prost S; Dausset J; Carosella E; Kirszenbaum M
    Hum Immunol; 1997 Jan; 52(1):41-6. PubMed ID: 9021408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of MHC-G4 and soluble (G5, G6) isoforms in the higher primates, Pongidae.
    Castro MJ; Morales P; Martinez-Laso J; Allende L; Rojo-Amigo R; Gonzalez-Hevilla M; Varela P; Moscoso J; Garcia-Berciano M; Arnaiz-Villena A
    Hum Immunol; 2000 Nov; 61(11):1164-8. PubMed ID: 11137222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells.
    Kestler DP; Agarwal S; Cobb J; Goldstein KM; Hall RE
    Blood; 1995 Dec; 86(12):4559-67. PubMed ID: 8541546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-G transcription studies during the different stages of normal and malignant hematopoiesis.
    Amiot L; Onno M; Renard I; Drénou B; Guillaudeux T; Le Bouteiller P; Fauchet R
    Tissue Antigens; 1996 May; 47(5):408-13. PubMed ID: 8795141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
    Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
    J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cells are the unique lymphocyte cell subset which do not express HLA-G.
    Teyssier M; Bensussan A; Kirszenbaum M; Moreau P; Gluckman E; Dausset J; Carosella E
    Nat Immun; 1995 Sep; 14(5-6):262-70. PubMed ID: 8933820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of HLA-G expression.
    Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
    Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of proteasome inhibitors on expression of HLA-G isoforms.
    Poláková K; Bandzuchová E; Bystrická M; Pancuchárová H; Russ G
    Neoplasma; 2006; 53(6):471-7. PubMed ID: 17167714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-G expression in human melanoma cells: protection from NK cytolysis.
    Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
    J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal/fetal interactions: the role of the MHC class I molecule HLA-G.
    Schmidt CM; Orr HT
    Crit Rev Immunol; 1993; 13(3-4):207-24. PubMed ID: 8110376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A soluble isoform of the rhesus monkey nonclassical MHC class I molecule Mamu-AG is expressed in the placenta and the testis.
    Ryan AF; Grendell RL; Geraghty DE; Golos TG
    J Immunol; 2002 Jul; 169(2):673-83. PubMed ID: 12097369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternatively spliced forms of MICA and MICB lacking exon 3 in a human cell line and evidence of presence of similar RNA in human peripheral blood mononuclear cells.
    Zou Y; Stastny P
    Immunogenetics; 2002 Dec; 54(9):671-4. PubMed ID: 12466900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Little evidence of HLA-G mRNA polymorphism in Caucasian or Afro-Caribbean populations.
    Bainbridge DR; Ellis SA; Sargent IL
    J Immunol; 1999 Aug; 163(4):2023-7. PubMed ID: 10438940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.